Bodal Chemicals Limited

NSE:BODALCHEM.NS

77.01 (INR) • At close November 8, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

2024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12013 Q12012 Q1
Revenue 4,219.623,935.873,385.53,299.993,324.854,038.173,157.83,957.314,589.535,734.585,618.084,697.054,218.134,272.293,661.493,097.351,178.163,553.63,263.573,077.143,722.783,196.043,343.113,932.123,517.222,812.923,072.232,561.342,856.171,764.6531,336.993
Cost of Revenue 2,701.662,386.691,649.981,717.191,715.472,318.791,716.392,408.012,598.596,825.193,091.42,674.432,256.513,663.362,337.721,970.87945.773,361.762,184.371,935.472,413.713,289.932,131.412,339.152,118.492,665.291,931.221,521.931,749.931,420.2131,172.889
Gross Profit 1,517.961,549.181,735.521,582.81,609.381,719.381,441.411,549.31,990.94-1,090.612,526.682,022.621,961.62608.931,323.771,126.48232.39191.841,079.21,141.671,309.07-93.891,211.71,592.971,398.73147.631,141.011,039.411,106.24344.44164.104
Gross Profit Ratio 0.360.3940.5130.480.4840.4260.4560.3920.434-0.190.450.4310.4650.1430.3620.3640.1970.0540.3310.3710.352-0.0290.3620.4050.3980.0520.3710.4060.3870.1950.123
Reseach & Development Expenses 0000044.1300049.4800040.1300036.2100029.55000000000
General & Administrative Expenses 000001,070.48000288.41000969.1000286.93000123.53000126.5400000
Selling & Marketing Expenses 0000014.0600015.7700012.500019.5200019.7800025.1300000
SG&A 1,319.391,308.111,223.671,087.94232.321,084.541,003.23980.1283.94304.18291.78284.261,232.53981.6210.15188.57189.92306.45209.01195.21180.12143.31183.52170.87158.87151.67125.49106.84113.2900
Other Expenses 24.6454.4746.4559.387.838.8722.2217.2137.83-142.1166.3517.5263.71-155.3370.145.7544.8-182.67871.280.0218.9-38.945.2830.3823.99-64.0520.3113.5932.8216.02298.858
Operating Expenses 1,319.391,308.111,641.91,491.091,533.871,596.741,334.631,350.611,615.96-1,573.211,959.181,635.051,569.267.791,013.19975.51514.65-182.67871.28951886.18-512.09709.94918.46806.61-427.12680.99651.46678.88216.02298.858
Operating Income 198.57241.07140.07151.0175.51161.51128.4215.9374.98484.68567.5387.57392.36601.14310.58150.97-282.26374.51207.92190.67422.892,009.75150.176674.51592.121,722.54746.002387.95427.3627.715-219.14
Operating Income Ratio 0.0470.0610.0410.0460.0230.040.0410.0550.0820.0850.1010.0830.0930.1410.0850.049-0.240.1050.0640.0620.1140.6290.0150.1720.1680.6120.0150.1510.150.016-0.164
Total Other Income Expenses Net -213.05-261.64-120.92-134.17-43.66-115.78-101.06-72.58-83-104.73-213.84-45.61-11.2-276.4435.4610.635.95-60.27-67.74-44.5-11.295.464-2.13110.067.7112.2470.7574.3212.64-100.71-84.386
Income Before Tax -14.48-20.5719.1516.8431.8545.7327.34143.32291.98379.95353.66341.96381.16324.7346.04161.6-276.31314.24140.18146.17411.6426.85480.45684.57599.83564.92467.59392.2744027.71-219.14
Income Before Tax Ratio -0.003-0.0050.0060.0050.010.0110.0090.0360.0640.0660.0630.0730.090.0760.0950.052-0.2350.0880.0430.0480.1110.1340.1440.1740.1710.2010.1520.1530.1540.016-0.164
Income Tax Expense -2.73-40.989.44.49.7617.623.0940.6266.791.51153.12106.1993.15107.3274.3851.26-76.7953.5811.66-66.55147.33133.19195.72234.29206.67169.77163.29136.9148.919.101-70.165
Net Income -11.7520.419.7512.4422.0928.1124.25102.69225.28308.74243.53228.33285.86235.72265.12116.16-195.43230.91144.57223.06274.84296.02296.29455.68384391.79295.36249.88288.5718.609-148.975
Net Income Ratio -0.0030.0050.0030.0040.0070.0070.0080.0260.0490.0540.0430.0490.0680.0550.0720.038-0.1660.0650.0440.0720.0740.0930.0890.1160.1090.1390.0960.0980.1010.011-0.111
EPS -0.0930.160.0780.0990.180.220.190.821.842.521.951.812.441.922.160.96-1.61.891.181.822.1610.782.333.693.149.341.892.642.640.17-1.37
EPS Diluted -0.0930.160.0780.0990.180.220.190.781.82.451.951.812.441.922.160.96-1.61.891.181.822.1610.782.333.693.149.341.892.642.640.17-1.37
EBITDA 368.91411.2285.22294.12309.84307.99267.62337.8536.13495.98749.61503.16552.7437.19456.33273.15-164.68407.2278.38257.72508.26485.24562.45758.8661.73558.33554.77474.45532.22168.944-93.581
EBITDA Ratio 0.0870.1040.0840.0890.0930.0760.0850.0850.1170.0860.1330.1070.1310.1020.1250.088-0.140.1150.0850.0840.1370.1520.1680.1930.1880.1980.1810.1850.1860.096-0.07